Swedbank AB Sells 27,522 Shares of HCA Healthcare, Inc. $HCA

Swedbank AB trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 15.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 147,298 shares of the company’s stock after selling 27,522 shares during the period. Swedbank AB’s holdings in HCA Healthcare were worth $68,768,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new position in HCA Healthcare in the fourth quarter valued at about $1,021,000. NewEdge Advisors LLC grew its stake in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the period. Sivia Capital Partners LLC grew its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the period. Jump Financial LLC acquired a new position in shares of HCA Healthcare during the second quarter worth about $2,073,000. Finally, Sei Investments Co. boosted its position in shares of HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $394.40 on Friday. The stock has a 50 day moving average price of $465.16 and a 200 day moving average price of $483.61. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The stock has a market capitalization of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.25 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the company posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on HCA shares. Sanford C. Bernstein reduced their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research report on Tuesday, April 28th. Robert W. Baird reduced their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. UBS Group upped their price objective on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Jefferies Financial Group reissued a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Weiss Ratings cut HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, May 18th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.